Duration and de-escalation of FOLFIRINOX as first-line chemotherapy in advanced pancreatic adenocarcinoma.
Year: 2025
Type: conference-abstract
Study design: Observational Study
Source: Journal of Clinical Oncology
Institutions: Dartmouth College, Texas Oncology, Dartmouth Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410813679
